Результаты поиска

Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications.

BACKGROUND: Cytarabine (Ara-C) remains the cornerstone of remission-induction and consolidation chemotherapy for acute myeloid leukemia (AML) and related hematological malignancies. Despite more than six decades of clinical use, its multi-organ toxicity continues to be managed almost exclusively through dose attenuation and supportive care, with no approved upstream pharmacological prevention strategy available. OBJECTIVES: This scoping review aimed to systematically map the breadth and nature of pharmacological agents tested in vivo for their capacity to mitigate cytarabine-induced multi-org

Просветительская работа с пациентами с помощью массового открытого онлайнового курса (МООК) для пациентов с множественными миеломами и лиц, обеспечивающих уход: описывающее исследование знаний, проведенное Французской ассоциацией пациентов с множественными миеломами (АФ3М) и французскоязычной межгруппой " Миэлома " (МФМ).

Множественная миелома (ММ) представляет собой хроническую гематологическую халатность, характеризующуюся сложными терапевтическими стратегиями, неоднократными рецидивами и существенными информационными и психосоциальными потребностями. Достижения в области пероральной терапии и амбулаторного лечения переложили бóльшую ответственность на пациентов и лиц, обеспечивающих уход, подчеркнув необходимость наличия доступных и высококачественных образовательных ресурсов. Терапевтическое просвещение пациентов (ТПЭ) направлено на то, чтобы помочь пациентам лучше понять свое состояние и более эффективно с

Machine learning and multi-omics technologies for precision cardiovascular medicine: advancing diagnosis, risk prediction, and therapeutic guidance.

Cardiovascular disease remains a major global health burden. Owing to its complex pathogenesis and marked clinical heterogeneity, conventional one-size-fits-all strategies often yield limited benefit for a substantial proportion of patients. Precision medicine advocates individualized management based on patients' clinical and molecular characteristics to improve outcomes. In this context, multi-omics and machine learning provide critical technical support for precision medicine: multi-omics can capture the full spectrum of cardiovascular disease from molecular alterations to phenotypic manife

Совпадение в полном тексте источника
… Large Language Models (LLMs) are a key component of generative AI. …

Which cancer survivors are at risk for a physically inactive and sedentary lifestyle? Results from pooled accelerometer data of 1447 cancer survivors.

BackgroundPhysical activity has beneficial effects on the health of cancer survivors. We aimed to investigate accelerometer-assessed physical activity and sedentary time in cancer survivors, and describe activity profiles. Additionally, we identify demographic and clinical correlates of physical activity, sedentary time and activity profiles.MethodsAccelerometer, questionnaire and clinical data from eight studies conducted in four countries (n = 1447) were pooled. We calculated sedentary time and time spent in physical activity at various intensities using Freedson cut-points. We used latent p

Predictive Factors for Failed Nonsurgical Management of Long Bone Metastasis and Myeloma.

BACKGROUND: Understanding the risk factors for failing nonsurgical management of metastatic bone disease is necessary to determine those patients who will benefit from prophylactic stabilization; however, standard predictive models do not include several clinically relevant factors. The primary and secondary objectives of this study were to evaluate comprehensive patient- and disease-related factors as potential predictors of failure of radiation therapy alone for long bone lesions and overall survival in metastatic disease and myeloma. METHODS: All patients who underwent radiation therapy fo

CRS and ICANS: Early detection and personalized management.

T-cell-redirected immunotherapies, including chimeric antigen receptor T-cell therapy and bispecific antibodies, have transformed the treatment of relapsed or refractory hematologic malignancies. However, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) remain the major immune-mediated toxicities that can complicate treatment delivery and contribute to morbidity and non-relapse mortality. CRS is characterized by systemic inflammatory amplification involving activated T cells, tumor cells, monocytes/macrophages, endothelial activation, and cytok

Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation.

Accurate prediction of mortality after allogeneic hematopoietic stem cell transplantation (alloHCT) is essential for individualized treatment decisions, yet existing clinical risk scores capture only a limited number of variables and show modest predictive performance. In our single-center retrospective analysis, we included data from 909 adult patients with hematologic malignancies undergoing alloHCT. We used 31 features to build machine-learning models to predict death within the first year after alloHCT. These features included established clinical risk factors together with pre-transplant

The clinical effectiveness and safety of traditional Chinese medicine uremic clearance granule combined with high-flux hemodialysis in the treatment of uremic pruritus: A protocol for systematic review and meta analysis.

BackgroundSkin pruritus is a common complication in patients with uremia. When the hemodialysis time of patients is extended, and the probability of skin pruritus is greater. Patients often have the symptoms of skin pruritus intolerable, affecting the normal sleep and normal life of patients. The patients with uremic pruritus often constant scratching and pruritus skin, resulting in broken skin, and further symptoms such as infection, and subsequent skin shedding, prurigo nodularis, and other adverse complications, aggravating the patient's condition. Some patients will experience symptoms suc

Acute Kidney Injury in Hospitalized Cancer Patients: Single-Centre Real-Life Analysis of Incidence and Clinical Impact.

Background: Acute kidney injury (AKI) is a frequent and clinically relevant complication in cancer patients, with highly variable incidence. AKI increases morbidity and mortality, prolongs hospitalization, and may limit access to oncologic therapies. This study evaluated the incidence, risk factors, and outcomes of AKI in hospitalized cancer patients. Methods: We retrospectively analyzed patients admitted between 1 January 2016 and 31 December 2019. Individuals with cancer were identified and categorized into three groups: hematologic malignancies, solid cancers with metastases, and solid canc

Проект для самостоятельной мотивации: Качественное собеседование по вопросам предприимчивости выживших жертв рака к программам изменения цифрового здоровья.

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Несмотря на повышенный риск рецидива, связанный с изменением образа жизни, многие лица, пережившие рак, не соблюдают рекомендации по укреплению здоровья. Цифровое медико-санитарное вмешательство открывает перспективы для поддержки изменений в поведении, однако лишь немногие исследования предусматривают участие выживших жертв в разработке мер вмешательства, что потенциально ограничивает эффективность реального мира. Понимание предпочтений и потребностей в поддержке выживших жертв рака имеет решающее значение для разработки эффективных мер по изменению поведения в цифровой

Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?

There is an increasing number of studies using real-world data to examine outcomes of drugs in clinical practice. Therefore, it is crucial to carefully evaluate their quality and findings, extract valuable insights, acknowledge their limitations and identify gaps to advance further their use in decision-making. Here we provide an overview of the opportunities offered throughout drug lifecycle, and challenges presented by real-world evidence (RWE) studies. We also highlight the importance of the culture of transparency, along with the development of good practices for reporting RWE studies. In

Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

To respond to the legitimate questions raised by the application of invasive methods of monitoring and life-support techniques in cancer patients admitted in the ICU, the European Lung Cancer Working Party and the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, set up a consensus conference. The methodology involved a systematic literature review, experts' opinion and a final consensus conference about nine predefined questions1. Which triage criteria, in terms of complications and considering the underlying neoplastic disease and possible therapeutic limitations, should be

Patient Engagement in Oncology Practice: A Qualitative Study on Patients' and Nurses' Perspectives.

Patient engagement has gained increasing attention in cancer care as it is widely acknowledged as an essential element of high-quality care. There are limited data on how oncology nurses might apply techniques that encourage patient engagement. Therefore, this study aims to understand which nursing strategies can favour patient engagement in oncological care from patients' and nurses' perspectives. We conducted a qualitative study involving oncology patients and oncology nurses. Patients were interviewed, while nurses were involved in focus groups (FGs). Both interviews and FGs were analysed b

What Is Most Important to Family Caregivers When Helping Patients Make Treatment-Related Decisions: Findings from a National Survey.

Prioritizing patient values-who/what matters most-is central to palliative care and critical to treatment decision making. Yet which factors are most important to family caregivers in these decisions remains understudied. Using data from a U.S. national survey of cancer caregivers (N = 1661), we examined differences in factors considered very important by caregivers when partnering with patients in cancer treatment decision making by cancer stage and caregiver sociodemographics. Fifteen factors were rated on a 4-point Likert-scale from 'very unimportant' to 'very important.' Descriptive statis

Инструменты и наборы инструментальных средств по лечению рака и психическому здоровью: обзор с целью анализа в соответствии с Руководящими принципами ПОРСМА-СКР.

Справочная информация: Наборы инструментальных средств/наборы инструментальных средств представляют собой перспективный инструмент для лечения раковых заболеваний и охраны психического здоровья. Однако для определения их ключевых компонентов и эффективных стратегий осуществления необходимы исследования. Методы: В соответствии с PRISMA-ScR поиск проводился по пяти базам данных с использованием ключевых терминов. Включены исследования по вопросам психического здоровья или лечения раковых заболеваний с использованием комплектов инструментов или инструментов для взрослых, документируются стратегии

Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.

Precision medicine has revolutionised targeted cancer treatments; however, its implementation in ovarian cancer remains challenging. Diverse tumour biology and extensive heterogeneity in ovarian cancer can limit the translatability of genetic profiling and contribute to a lack of biomarkers of treatment response. This review addresses the barriers in precision medicine for ovarian cancer, including obtaining adequate and representative tissue samples for analysis, developing functional and standardised screening methods, and navigating data infrastructure and management. Ethical concerns relat

Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study.

PurposeDistress screening has become mandatory and essential in comprehensive cancer care. We evaluated an electronic psycho-oncological adaptive screening (EPAS) which assesses objective indicators of care needs and subjectively perceived care needs and subsequently provides patient feedback with individualized recommendations about psychosocial care services.MethodsPatients were assessed within clusters, i.e., different oncological facilities of the competence network of the University Cancer Center Hamburg (UCCH). Patients in the intervention arm underwent the screening, controls received s

Постройте мышцы и защитите миелина.

Множественный склероз (MS) представляет собой хроническое и изнуряющее аутоиммунное заболевание центральной нервной системы (СНС), при котором иммунная реакция, основанная на CNS, разрушает миелин, что приводит к широкому спектру симптомов, включая онемение и покалывание, проблемы зрения, нарушение подвижности и т.д. Oligodendrocytes — это миелионирующие клетки в CNS, которые образуются из олигодендроголовых потомков (OPC) посредством дифференциации. Однако по целому ряду причин ОЗК не проводят различия с олигодендроцитами в РС, и в результате, стимулирование дифференциации ОЗК с олигодендроци

Совпадение в полном тексте источника
… Use of Large Language Models, AI and Machine Learning Tools: We did not use large language models and AI and machine learning tools while writing this review. Conflict of interest: The authors state no conflict of interest. …

Clinical context and communication in shared decision-making about major surgery: Findings from a qualitative study with colorectal, orthopaedic and cardiac patients.

Increasing numbers of older people undergo major surgery in the United Kingdom (UK), with many at high risk of complications due to age, co-morbidities or frailty. This article reports on a study of such patients and their clinicians engaged in shared decision-making. Shared decision-making is a collaborative approach that seeks to value and centre patients' preferences, potentially addressing asymmetries of knowledge and power between clinicians and patients by countering medical authority with greater patient empowerment. We studied shared decision-making practices in the context of major su

How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnership.

BACKGROUND: Over the last decade there has been considerable research into the treatment, management, and quality of life of people living with multiple myeloma. However, there has been limited investigation into topics deemed important to patients and caregivers within this community. We conducted a James Lind Alliance Priority Setting Partnership to establish the 'Top 10 Priorities for Myeloma Research', informed by patient and public partners. METHODS: A research team and steering group were established in 2019 to conduct the myeloma priority setting partnership. Steering group members inc